Testing a new drug in healthy volunteers
Part of Immune system & allergy, Skin clinical trials.
This trial tests an experimental drug called HRS-3095 in healthy people to check its safety and how the body handles it. It may help find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy white adult between 18 and 55 years old.
- Your body weight must be at least 45 kg (99 lbs) if you are a woman, or 50 kg (110 lbs) if you are a man, and your body mass index (BMI) must be between 19 and 30.
- You must agree to use highly effective birth control during the study if you or your partner can become pregnant.
- You cannot have any major medical conditions or allergies to the study drug or similar medications.
- You must not have used any other experimental drug or device in the last 3 months (or longer, depending on the drug).
- You must not smoke heavily, abuse drugs, or have a history of drug addiction in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental capsule (HS-10561) to see if it is safe and works for people with chronic spontaneous urticaria, which causes hives and itching without a clear trigger. If you have had hives for at least 6 months, you might be able to join.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This study tests a new medication called HRS-3095 to see if it can help people whose chronic hives (itchy welts) do not get better with standard allergy pills. It aims to reduce itching and wheals and improve quality of life.
This is an early-stage study testing a new experimental drug called EDP-978 in healthy volunteers to see if it is safe and how the body processes it. Researchers will give participants single or multiple doses and monitor for side effects and how the drug moves through the body.
This trial tests a new injectable medicine (JYB1904) to see if it can reduce itching and hives better than standard antihistamines alone. If you have chronic hives with no clear cause and still get symptoms despite taking antihistamines, this study may be an option for you.
This trial tests a new medicine, JYB1904, for people with chronic hives (itching and welts) that haven't been controlled by standard allergy pills. It aims to see if JYB1904 can reduce itching and hives better.
Hear when a new Chronic Spontaneous Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.